Jan 25, 2026
Diabetic cure
There is no universally accepted, single "" for diabetes today, but multiple promising, disease-modifying approaches are converging—especially for type 1 diabetes () via , gene and immune therapies, a...
Your fact-checks will appear here
Company in Shanghai, China
There is no universally accepted, single "" for diabetes today, but multiple promising, disease-modifying approaches are converging—especially for type 1 diabetes () via , gene and immune therapies, a...
Since 2020, reporting and research highlight several major advances in type 2 diabetes (T2D) care: approval and wider adoption of GLP‑1 receptor agonists including an oral GLP‑1, emergence of dual‑ago...